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Mouse myeloid leukemic Ml cells can be induced to differentiate into macrophages and granulocytes in 
vitro by a protein inducer (D-factor) in body fluids and conditioned media from various cells and tissues. 
Antiserum to D-factor was prepared by immunizing a rabbit with D-factor partially purified from 
conditioned medium of mouse L929 cells. At 1:20 dilution, the antiserum nearly completely suppressed 
the activities of various D-factor preparations from mice and partially suppressed the activities of 
preparations from rats and hamsters. It did not cross-react with factors stimulating colony formation of 
macrophages and granulocytes from normal bone marrow cells. 
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1. INTRODUCTION 
Mouse myeloid leukemic Ml cells can be induc- 
ed to differentiate either in vitro or in vivo by a 
protein inducer (D-factor) and various chemicals 
[l-3]. D-factor has also been referred to as MCI-2 
[4] and has been found in culture fluids of various 
cells and tissues, including mouse embryo cells 
[ 1,5], hamster embryo cells [a], mouse spleen 
lymphocytes [7], mouse fibroblast L cells [8], rat 
YS cells [9] and mouse lung [lo], and in body fluids 
such as ascitic fluids [l l] and serum of mice in- 
jected with bacterial endotoxins [ 121. D-factors are 
heterogenous in molecular size and charge [2] and 
the relation of D-factors from different sources is 
still unknown. 
Preparations of D-factor all contain CSF activi- 
Abbreviations: D-factor, differentiation-stimulating fac- 
tor; MGI, macrophage and granulocyte inducer; CSF, 
colony-stimulating factor; G-CSF, granulocyte colony- 
stimulating factor; CM, conditioned medium 
ty essential for the in vitro growth of granulocyte 
and macrophage colonies from normal bone mar- 
row cells. The relation between D-factor and CSF 
is not well understood. We [7] previously showed 
that D-factor and CSF in conditioned medium of 
mouse spleen cells stimulated with Con A or lipo- 
polysaccharide were distinct substances. Further- 
more, we [8] recently found that mouse L cells pro- 
duced D-factor which was a glycoprotein with a M, 
of 50000-70000 and that it could be separated 
from CSF by gel filtration. However, in [4] it was 
reported that D-factor from conditioned medium 
of Krebs ascites tumor cells was separated from the 
bulk of CSF activity but not from some residual 
CSF activity. 
To elucidate the relation of D-factors from dif- 
ferent sources and the role of D-factor in growth 
and differentiation of normal bone marrow cells, 
we prepared antiserum to D-factor from L cells. 
This paper reports studies on the neutralization of 
D-factors and CSF’s from various sources by the 
antiserum. 
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2. MATERIALS AND METHODS 
2.1. Assay of D-factor 
Activity of D-factor was assayed by measuring 
induction of phagocytic activities in Ml cells (clone 
T-22) as in [ 131. Ml cells (5 x lo5 cells) were in- 
cubated for 2 days in 1 ml of Eagle’s minimal 
essential medium containing D-factor, and then in- 
cubated further for 4 h with a suspension of poly- 
styrene latex particles. Cells containing more than 
10 latex particles were scored as phagocytic cells. 
Induction of phagocytic cells was proportional to 
the concentration of D-factor. Data in the present 
experiments were obtained in the linear dose-- 
response range. Fifty units of D-factor was defined 
as the activity inducing 50% phagocytic cells under 
these conditions. 
2.2. Purification of D-factor from L cells 
Serum-free conditioned medium of L929 cells 
was prepared as in [15]. D-factor was precipitated 
from the medium with 90% saturation of am- 
monium sulfate, applied to a Sephadex G-200 col- 
umn as in [S], and then chromatographed on a 
Phenyl-Sepharose column as in [ 161. 
2.3. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis in the 
presence of SDS was performed essentially as in 
[17]. Gels (5 x 110 mm) containing 7.5% poly- 
acrylamide were used. D-factor (2500 units, 55 pg 
of protein) was allowed to stand for 30 min at 
room temperature in the presence of 1% SDS 
before the run, and then subjected to electro- 
phoresis at 7 mA/gel for55 h&&ions (2&mn) 
of the gel were eluted overnight with 0.25 ml of 
phosphate-buffered saline containing 0.1% bovine 
serum albumin at room temperature, and O.l-ml 
samples of the eluates were assayed for D-factor 
activity. Bovine serum albumin (Mr 68000), 
ovalbumin (MI 45000) and trypsin inhibitor (Mr 
21500) were used as marker proteins. 
2.4. Preparation of anti-D-factor antiserum 
A rabbit was immunized by intradermal injec- 
tion of partially purified L cell D-factor in 50% 
Freund’s complete adjuvant at intervals of 2 
weeks; it was injected 5-times with 1000 units of D- 
factor (22pg of protein) and then 4-times with 
5000 units of D-factor. The resulting serum was 
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heated at 56°C for 30 min. IgG was separated on 
Protein A Sepharose CL4B (Pharmacia Fine 
Chemicals) as in [18]. 
2.5. Sources of D-factor and CSF 
Conditioned medium of mouse lung tissue [lo], 
L cells [8], mouse embryo cells [19], hamster em- 
bryo cells [6], mouse macrophage-like Mm-l cells 
[20], mouse spleen cells stimulated with Con A [7] 
and rat Yoshida sarcoma cell line YS-T22 cells [9], 
mouse endotoxin serum [12] and ascitic fluid of 
rats bearing AH130 hepatoma cells [ 1 l] were 
prepared as described before. 
2.6. Assay of CSF 
CSF was assayed as in [7]. Bone marrow cells 
(10’) of adult ICR mice were seeded into a 35 mm 
petri dish containing 1 ml of 0.3% agar medium 
and CSF preparation. After incubation for 7 days, 
the number of colonies was counted. Data were ob- 
tained in the concentration range giving a linear 
dose-response relationship. The morphology of 
cells was determined in whole-mount preparations 
[14] stained with Giemsa solution. 
3. RESULTS 
3.1. Partial purification of D-factor from 
conditioned medium of L cells 
D-factor was concentrated from serum-free condi- 
tioned medium of L cells by ammonium sulfate 
precipitation. Although CSF from L cells was 
eluted in several fractions on gel filtration, most of 
the D-factor activity was separated from CSF ac- 
tivity by gel filtration on Sephadex G-200, as in [8]. 
The resulting preparation of D-factor was then 
purified further by Phenyl-Sepharose chromato- 
graphy. The purified D-factor preparation had a 
specific activity of 60-times that of the original 
conditioned medium. When this preparation was 
subjected to electrophoresis on polyacrylamide gel 
in the presence of SDS, a protein band associated 
with D-factor activity was observed. This protein 
constituted 3.5% of the total protein in the gel, 
judging from the densitometer tracing (fig.1). On 
treatment of Ml cells (clone T-22) with 100 units of 
the D-factor preparation, nearly all the cells differ- 
entiated into macrophage-like cells by day 4 and no 
granulocytic cells were observed (unpublished). 
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Fig. 1. SDS-polyacrylamide gel electrophoresis of parti- 
ally purified D-factor of L cells. Fractions were assayed 
for ability to induce phagocytic activity in Ml cells 
(O-O). Another gel run in parallel was stained for pro- 
tein with Coomassie Brilliant Blue and scanned with a 
microdensitometer (- )* 
3.2. Production of antiserum against L cell 
D-factor 
Initially, 6 rabbits were immunized with 1000 
units of D-factor preparation, purified as describ- 
ed above. Even after 5 injections of the D-factor, 
the titers of sera from 6 rabbits for 50% inhibition 
of D-factor were below 1: 20. When one of the rab- 
bits was then injected 4-times more with 5000 units 
of the D-factor, the titer of this serum for 50% in- 
hibition was 1: 100. This serum at 1:20 dilution 
completely inhibited induction of phagocytic ac- 
tivity in Ml cells by L cell D-factor (fig.2). 
However, it did not inhibit induction of phagocytic 
cells when added 24 h after treatment of Ml cells 
with D-factor. Ml cells can also be induced to 
differentiate by dexamethasone, lipopoly- 
saccharide or poly(1) [2]. The antiserum did not in- 
hibit induction of phagocytic cells by these in- 
ducers (not shown). Untreated control rabbit 
serum did not significantly inhibit D-factor activi- 
ty. IgG purified from the antiserum on Protein A- 
Sepharose inhibited D-factor activity. These results 
indicate that inhibition of D-factor activity was the 
direct result of an anti-D-factor antibody rather 
than of non-specific factors. 
3.3. Neutralization of D-factor from various 
sources 
Fig.3. Neutralization of D-factor from various sources: 
(a) Murine D-factor from various sources was treated 
with various concentrations of antiserum to D-factor of 
L cells as described in the legend to fig.2 and then assay- 
ed for D-factor activity. Sources of D-factor: 0.5,ml of 
L cell CM (0); 0.5 ml of mouse embryo CM (A); 
0.1 ml of mouse spleen cell CM (0); 25 ,~l of mouse lung 
CM (0); 38 pl of mouse endotoxin serum (A); (b) Sour- 
ces of D-factor: 0.5 ml of L cell CM (0); 0.4 ml of 
hamster embryo CM (A); 0.4 ml of rat YS cell CM (0); 
Cross-reactivity against various D-factor pre- 0.5 ml of rat ascitic fluid (0). 
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Fig.2. Neutralization of D-factor of L cells by its antibo- 
dy. Conditioned medium of L cells (0.5 ml) was treated 
with various concentrations of antiserum (0); IgG puri- 
fied from the antiserum (0); or control serum (A) at 
room temperature for 30 min. Then it was adjusted to a 
total volume of 1 ml with culture medium and assayed 
for D-factor activity. The percentage of antiserum was 
expressed as the final concentration in 1 ml of medium. 
parations was examined with antiserum to D- 
factor of L cells. The antiserum at 1:20 dilution 
almost completely neutralized the D-factor activity 
of various mouse preparations including endotoxin 
serum and conditioned media from L cells, embryo 
cells, spleen cells stimulated with Con A and lung 
tissue (fig.3a). It also inhibited D-factor activity in 
rat ascitic fluid and conditioned media of rat 
Antiserum (%I 
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Yoshida sarcoma cells and hamster embryo cells, 
although its extents of inhibition were less than 
with mouse D-factor (fig.3b). 
3.4. Effect of anti-D-factor antibody on CSF 
activity 
For examination of the relation between D- 
factor and CSF, several CSF preparations were 
treated with the antibody to D-factor of L cells. 
Since the untreated antiserum and control rabbit 
serum slightly enhanced colony formation from 
normal bone marrow cells by L cell CSF, purified 
anti-D-factor IgG was used in the experiments. 
This IgG did not inhibit the CSF activities of con- 
ditioned media from L cells, lung tissue, mouse 
Mm-l cells or rat Yoshida sarcoma cells. Further- 
more, it did not change the proportions of granulo- 
cyte and macrophage colonies significantly (table 
1). 
4. DISCUSSION 
D-factors for myeloid leukemic Ml cells have 
shown to be heterogeneous in molecular size and 
charge [2]. Here, we showed that the antigenic pro- 
perties of D-factor from various preparations from 
mice were similar to those of D-factor from mouse 
L cells. D-factors from rats and hamsters were also 
neutralized by the antibody to D-factor of L cells, 
Table 1 
Effect of anti-D-factor antibody on CSF activitya 
CSF Anti- No. of Colony type (o’lo) 
body colonies 
G M Mix 
L cell CM _ 109 + 20 0 95 5 
(50 Pl) + 108+11 0 97 3 
Lung CM - 70 + 5 53 20 27 
(50 rl) + 77 + 10 47 22 31 
Mm-l cell CM - 29 + 4 34 31 35 
(150 rl) + 28 + 4 46 32 22 
YS cell CM _ 54 + 2 41 38 21 
(150 Pl) + 46 f 3 42 36 22 
a Various CSF preparations were treated with purified 
IgG equivalent to 0.1 ml of original antiserum at room 
temperature for 30 min and assayed for CSF activity. 
Colony type: granulocytes (G), macrophages (M) and 
a mixture of granulocytes and macrophages (Mix) 
b Ten-times concentrated 
but the titers of inhibition were somewhat less than 
those observed with mouse D-factor. The activities 
of L cell CSF (M-CSF) and lung CSF (GM-CSF) 
were not inhibited by the antibody. 
Besides Ml cells, a mouse myelomonocytic 
leukemic cell line, WEHI-3B cells, can also be in- 
duced to differentiate into macrophages and 
granulocytes by a differentiation factor (DF) ob- 
tained from similar sources to those of the D- 
factor for Ml cells [16,21,22]. A similar 
substance(s) is probably responsible for the induc- 
tions of differentiation of Ml cells and WEHI-3B 
cells. The DF activities in conditioned media of 
mouse lung and endotoxin serum could be 
separated from the bulk of GM-CSF and M-CSF 
activities, but not from some G-CSF activity [ 161. 
However, in [22] G-CSF from WEHI-3B-D- cells 
(a differentiation-noninducible cell line) did not in- 
duce differentiation of WEHI-3B-D+ cells (a 
differentiation-inducible cell line). Since DF 
preparations for WEHI cells and D-factor prepara- 
tions for Ml cells with CSF activity have not yet 
been purified to homogeneity [4,16], there is no 
evidence at present hat D-factor or DF is a subset 
of CSF. 
Although D-factor or DF seems to be important 
for suppression of development of myeloid 
leukemia [2,3,21], the roles of these factors in nor- 
mal hematopoiesis are unknown. In [23] it was 
claimed that CSF induced growth of normal pre- 
cursor cells of granulocytes and macrophages and 
induced production of D-factor by the precursor 
cells, that caused their own differentiation. We are 
now purifying D-factor further to elucidate its true 
target cells in vivo. 
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